Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Lamarca

Showing results (131-140 of 201) with videos related to

Pageof 21
Sort By:
Neuroendocrinology|February 1, 2019
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine CarcinomasMelissa Frizziero, Francesca Spada, Angela Lamarca, et al.
Human Pathology|May 14, 2017
The dark side of T1 non-appendiceal small bowel neuroendocrine tumorsZena Salih, Angela Lamarca, Daisuke Nonaka, et al.
Pancreas|December 3, 2021
Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer: Validation of an Algorithm for Dose Escalation and ManagementLindsay E Carnie, Kelly Farrell, Natalie Barratt, et al.
Pancreas|February 4, 2020
The Influence of Patients' Age on the Outcome of Treatment for Pancreatic Ductal AdenocarcinomaAbdullah K Malik, Angela Lamarca, Ajith Kumar Siriwardena, et al.
Oncotarget|March 31, 2018
PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumoursAngela Lamarca, Daisuke Nonaka, Wolfgang Breitwieser, et al.
British Journal of Cancer|November 22, 2017
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined responseAngela Lamarca, Jorge Barriuso, Matthew Kulke, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
The Management and Outcomes of Patients with Extra-Pulmonary Neuroendocrine Neoplasms and Brain MetastasesZainul-Abedin Kapacee, Jennifer Allison, Mohammed Dawod, et al.
Cancer Treatment Reviews|March 17, 2021
Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysisEsmeralda Garcia-Torralba, Francesca Spada, Kok Haw Jonathan Lim, et al.
Journal of the National Cancer Institute|January 29, 2017
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine CarcinomasAngela Lamarca, Thomas Walter, Marianne Pavel, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 30, 2025
SEOM-GEMCAD-TTD clinical guidelines for biliary tract cancer (2025)Teresa Macarulla, Jorge Adeva, Maria Teresa Cano Osuna, et al.
Pageof 21

Showing results (131-140 of 201) with videos related to

Sort By:
Pageof 21
Neuroendocrinology|February 1, 2019
Carboplatin in Combination with Oral or Intravenous Etoposide for Extra-Pulmonary, Poorly-Differentiated Neuroendocrine CarcinomasMelissa Frizziero, Francesca Spada, Angela Lamarca, et al.
Human Pathology|May 14, 2017
The dark side of T1 non-appendiceal small bowel neuroendocrine tumorsZena Salih, Angela Lamarca, Daisuke Nonaka, et al.
Pancreas|December 3, 2021
Pancreatic Enzyme Replacement Therapy for Patients Diagnosed With Pancreaticobiliary Cancer: Validation of an Algorithm for Dose Escalation and ManagementLindsay E Carnie, Kelly Farrell, Natalie Barratt, et al.
Pancreas|February 4, 2020
The Influence of Patients' Age on the Outcome of Treatment for Pancreatic Ductal AdenocarcinomaAbdullah K Malik, Angela Lamarca, Ajith Kumar Siriwardena, et al.
Oncotarget|March 31, 2018
PD-L1 expression and presence of TILs in small intestinal neuroendocrine tumoursAngela Lamarca, Daisuke Nonaka, Wolfgang Breitwieser, et al.
British Journal of Cancer|November 22, 2017
Determination of an optimal response cut-off able to predict progression-free survival in patients with well-differentiated advanced pancreatic neuroendocrine tumours treated with sunitinib: an alternative to the current RECIST-defined responseAngela Lamarca, Jorge Barriuso, Matthew Kulke, et al.
Current Oncology (Toronto, Ont.)|July 25, 2022
The Management and Outcomes of Patients with Extra-Pulmonary Neuroendocrine Neoplasms and Brain MetastasesZainul-Abedin Kapacee, Jennifer Allison, Mohammed Dawod, et al.
Cancer Treatment Reviews|March 17, 2021
Knowns and unknowns of bone metastases in patients with neuroendocrine neoplasms: A systematic review and meta-analysisEsmeralda Garcia-Torralba, Francesca Spada, Kok Haw Jonathan Lim, et al.
Journal of the National Cancer Institute|January 29, 2017
Design and Validation of the GI-NEC Score to Prognosticate Overall Survival in Patients With High-Grade Gastrointestinal Neuroendocrine CarcinomasAngela Lamarca, Thomas Walter, Marianne Pavel, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|May 30, 2025
SEOM-GEMCAD-TTD clinical guidelines for biliary tract cancer (2025)Teresa Macarulla, Jorge Adeva, Maria Teresa Cano Osuna, et al.
Pageof 21